These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2967265)

  • 21. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
    Nilsson-Ohman J; Fredrikson GN; Nilsson-Berglund LM; Gustavsson C; Bengtsson E; Smith ML; Agardh CD; Agardh E; Jovinge S; Gomez MF; Nilsson J
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1465-70. PubMed ID: 19755528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of radioimmunosuppression on the development of low-dose streptozotocin diabetes.
    Hahn HJ; Barnstorf K; Nadrowitz R; Besch W; Schmidt W
    Acta Biol Med Ger; 1982; 41(12):1191-7. PubMed ID: 6231787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
    Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
    Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins.
    Kolb H; Oschilewski M; Schwab E; Greulich B; Roos P; Kiesel U
    Diabetes Res; 1986 May; 3(4):183-6. PubMed ID: 3742941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylactic effect of cyclic AMP on alloxan diabetes in mice].
    Kojima R; Hayashi M
    Igaku To Seibutsugaku; 1971 Nov; 83(5):265-8. PubMed ID: 4339141
    [No Abstract]   [Full Text] [Related]  

  • 27. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes.
    Shertzer HG; Schneider SN; Kendig EL; Clegg DJ; D'Alessio DA; Genter MB
    Biochem Pharmacol; 2008 Mar; 75(6):1402-10. PubMed ID: 18237716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
    Lin B; Zhang ZL; Yu LY; Guo LH
    Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.
    Sandler S; Andersson A
    Diabetologia; 1982 Oct; 23(4):374-8. PubMed ID: 6292033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial protection against streptozotocin-induced hyperglycaemia by superoxide dismutase linked to polyethylene glycol.
    Asplund K; Grankvist K; Marklund S; Täljedal IB
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):390-4. PubMed ID: 6239493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery from experimental diabetes mellitus in mice after pancreas transplantation.
    Kramp RC; Congdon CC; Smith LH
    Diabetes; 1974 Mar; 23(3):183-8. PubMed ID: 4274025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Energetic fuels in the blood of the rats with streptozotocin induced diabetes mellitus (author's transl)].
    Spiroski M; Kovacev V
    God Zb Med Fak Skopje; 1979 Jan; 25():169-80. PubMed ID: 162470
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes mellitus in mice induced by multiple subdiabetogenic doses of streptozotocin: age and sex dependence.
    Kuttler B; Schneider E
    Acta Biol Med Ger; 1982; 41(12):1199-1202. PubMed ID: 6231788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
    Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
    Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
    Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
    Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
    Kiesel U; Falkenberg FW; Kolb H
    J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melphalan attenuates streptozotocin-induced diabetes in C57BL/6 and C3H3 mice.
    Biener J; Flechner I; Laron Z
    Isr J Med Sci; 1988 Mar; 24(3):190-1. PubMed ID: 2967265
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.